Stock listing

OTC:BTHE Boston Therapeutics Inc Stock

Follow Boston Therapeutics Inc into a list and get an email when it puts out news.

Delisted OTC:BTHE no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
OTC:BTHE
Asset type
Stock
Exchange
OTC
Currency
USD

Boston Therapeutics Inc on 6ix

Decks
4 decks · latest Nov 5, 2021

Decks

DeckKindSlidesDate
Investor Presentation (November 2021)Investor deck21 slidesNov 5, 2021
Investor Presentation (June 2018)Investor deck18 slidesJun 1, 2018
Investor Presentation (October 2012)Investor deck32 slidesOct 10, 2012
Investor Presentation (April 2012)Investor deck15 slidesApr 27, 2012

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Dale H. Conaway
Other companies: Bioxytran, Inc. (Director · Since at least Jul 1, 2020); Galectin Therapeutics Inc. (Director · Mar 9, 2006 – Feb 8, 2009 · Past)
Director · Apr 4, 2014 – May 15, 2015 · Past
Anthony Don Squeglia
Other companies: Galectin Therapeutics Inc. (Chief Financial Officer · Oct 1, 2007 – Feb 2, 2010 · Past)
Chief Financial Officer · Dec 3, 2013 – Mar 10, 2015 · Past
Jonathan B RomeChief Operating Officer (3) · Jan 29, 2014 – Jan 29, 2014 · Past
Kenneth A Tassey JrCEO, President, Director · Mar 23, 2012 – Feb 12, 2014 · Past
Loraine UphamChief Operating Officer · Feb 12, 2018 – Feb 12, 2018 · Past
Rom E EliazDirector · Apr 4, 2014 – Apr 4, 2014 · Past

Open People

Log in to ask 6ix AI your own questions about Boston Therapeutics Inc.